Quercetin induces apoptosis and enhances 5-FU therapeutic efficacy in hepatocellular carcinoma

Quercetin Enhances Chemosensitivity to Gemcitabine in Lung Cancer Cells by Inhibiting Heat Shock Protein 70 Expression

(2015) Seung Hyeun Lee et al.   Clinical Lung Cancer

Quercetin Induces Antiproliferative Activity Against Human Hepatocellular Carcinoma (HepG2) Cells by Suppressing Specificity Protein 1 (Sp1)

(2015) Ra Ham Lee et al.   DRUG DEVELOPMENT RESEARCH

Antiproliferative activity of long chain acylated esters of quercetin-3-O-glucoside in hepatocellular carcinoma HepG2 cells

(2015) Sudhanshu Sudan et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU

(2015) Xin Li et al.   Oncotarget

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Low Concentration of Quercetin Antagonizes the Cytotoxic Effects of Anti-Neoplastic Drugs in Ovarian Cancer

(2014) Na Li et al.   PLoS One

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2012)   EUROPEAN JOURNAL OF CANCER

Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review

(2011) Naval Bajwa et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma

(2011) Amal A Mohamed et al.   Virology Journal

Targeting survivin in cancer: patent review

(2010) Jagat R Kanwar et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Pharmacological Inhibition of the Bcl-2 Family of Apoptosis Regulators as Cancer Therapy

(2010) Alan Richardson et al.   Current Molecular Pharmacology

Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics

(2008) A. C. Mita et al.   CLINICAL CANCER RESEARCH